Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Too good to believe, especially when the BOD members hold very little stock, is
Reply New Message
Prev Message Back To Forum Threaded View Next Message

That was the situation in the past and it has not changed. INTC recently agreed to pay NVDA 1.5 BILLION DOLLARS for infringement damages and a patent license. Could we be the next NVDA??? Big risk MAY equal big reward???

Could PTSC be the next NVDA? No. Ignoring all the other incongruities in the comparison, most importantly PTSC has already sold a license to INTC. They are done with INTC.

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply